Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) reports a growth of 229% in revenues to $7.7 million in 2020. It includes the revenues of its subsidiary The Sera Labs Inc. The company’s profits rose by 150% to $1 million in 2020.
In the pharmacokinetics (PK) study, which evaluates the bioavailability of the CUREfilm delivery system compared with softgels, Cure Pharmaceutical received positive indications.
Receives approval of FDA for Curefilm IND Blue
The US FDA approved Cure Pharmaceutical’s IND of CUREfilm. It is an oral soluble form of an active ingredient in Viagra – sildenafil citrate and designed to treat erectile dysfunction (ED) in men.
CUREfilm is designed to provide a better experience to the patients. Cure Pharmaceutical is progressing towards the commercialization of this product by roping in partners.
The Sera Labs selects Nicole Kidman as a business partner
The Sera Labs entered a deal with Nicole Kidman, who will act as a business partner. Nicole will also act as a brand ambassador for The Sera Labs topical products.
Nicole will also play a vital role in product development. CSO of Cure Pharmaceutical and CEO of The Sera Labs, Nancy Duitch, said the company is excited that Nicole agreed to join the team at The Sera Labs.
The company is pleased to work with Nicole, who cares to grow its business. Nicole experimented with topical CBD to treat an ankle injury the last summer. She will also contribute her experience in the beauty sector to improve the multi-channel distribution efforts of The Sera Labs.
Nicole will also play a vital role in promoting topical ultra-hydrating/ pain relief body creams, Sera topical, and Serums. She will also participate in the development and launch of three key products in 2021 besides the existing nine topical products of The Sera Labs.
CSO of Cure Pharmaceutical, Rob Davidson, and The Sera Labs CEO will attend a virtual conference to discuss investing in Cannabis on April 20, 2021. They will also discuss topics such as the patented drug delivery technology of Cure Pharmaceutical to deliver nutraceutical ingredients and cannabinoids.
Cure Pharmaceutical achieved significant growth in 2020 because of the takeover of Sera Labs and scientific advances.
 Reports Revenues Of $7.7 Million In 2020){kind=link}